Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PMGC Holdings Inc. - Common Stock (NQ:ELAB)

0.8960 -0.0529 (-5.57%)
Streaming Delayed Price Updated: 9:50 AM EDT, Jul 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 131,378
Open 0.9398
Bid (Size) 0.8910 (100)
Ask (Size) 0.8975 (100)
Prev. Close 0.9489
Today's Range 0.8848 - 0.9408
52wk Range 0.9036 - 309.89
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
NorthStrive Defense Tech Executes Definitive Exclusive License Agreement with Florida State University Research Foundation for Multi-Domain Drone Payload Technology Across Defense, Aerospace and Maritime Applications
From PMGC Holdings Inc.
Via GlobeNewswire
The market is filled with gapping stocks in Friday's session. ↗
Via Chartmill

Performance

YTD
-97.4%
-97.4%
1 Month
-32.1%
-32.1%
3 Month
-69.5%
-69.5%
6 Month
-95.9%
-95.9%
1 Year
-99.5%
-99.5%

More News

Read More
These stocks that are showing activity before the opening bell on Friday. ↗
Via Chartmill
News headline image
NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression
From PMGC Holdings Inc.
Via GlobeNewswire
Thursday's after hours session: top gainers and losers ↗
Via Chartmill
News headline image
PMGC Holdings Inc. Announces Merger of AGA Precision Systems into A&B Aerospace
From PMGC Holdings Inc.
Via GlobeNewswire
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Highlights Advanced Precision Manufacturing Capabilities Supporting Space Exploration Supply Chains
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
NorthStrive Defense Tech Executes Binding Agreement to Acquire Exclusive License to Patented Multi-Domain Drone Payload Technology for Defense, Aerospace and Maritime Applications
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor Markets
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
GB Capital Ltd. Co-Advises on the Acquisition of A&B Aerospace Inc.
From GB Capital Ltd.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q1 2026 Results and Files Form 10-Q; Total Assets Reach Over $26.0 Million, Up 102% from Year-End 2025 and 193% Year-over-Year
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings (NASDAQ: ELAB) Acquires A&B Aerospace, Inc.
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions related to GLP-1 Use, Sarcopenia, Muscle Disuse Atrophy, and Certain Neurological Disorders
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
NorthStrive Defense Tech Acquires Patented GPS-Denied Autonomous Drone Navigation Technology Option, Built for Defense and Counter-Unmanned Aircraft Systems
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
SVM Machining, Inc. Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products Co., Inc.
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings, Inc. (Nasdaq: ELAB) Secures $40 Million Equity Purchase Facility Agreement: Announces Ability To Accelerate M&A Strategy Currently Focused on Acquiring Aerospace and Defense Manufacturing Companies
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
What's Going On With PMGC Holdings Stock? ↗
Via Benzinga
News headline image
NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant Biosciences
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
Why PMGC Holdings Stock Is Falling Friday? ↗
Via Benzinga
News headline image
Pacific Sun Packaging to Showcase Solutions at ITAD Europe 2026, Targeting Global Market Expansion
From PMGC Holdings Inc.
Via GlobeNewswire
Which stocks are experiencing notable movement on Thursday? ↗
Via Chartmill

Frequently Asked Questions

Is PMGC Holdings Inc. - Common Stock publicly traded?
Yes, PMGC Holdings Inc. - Common Stock is publicly traded.
What exchange does PMGC Holdings Inc. - Common Stock trade on?
PMGC Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PMGC Holdings Inc. - Common Stock?
The ticker symbol for PMGC Holdings Inc. - Common Stock is ELAB on the Nasdaq Stock Market
What is the current price of PMGC Holdings Inc. - Common Stock?
The current price of PMGC Holdings Inc. - Common Stock is 0.8960
When was PMGC Holdings Inc. - Common Stock last traded?
The last trade of PMGC Holdings Inc. - Common Stock was at 07/24/26 09:50 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.